课题基金 / 基金详情

IGF::OT::IGF Vascular Interventions/Innovations and Therapeutic Advances (VITA): A Study to Explore the Feasibility of using Combined Modalities to Test the Safety of CaridMEMS Device in PAH Patients

IGF::OT::IGF Vascular Interventions/Innovations and Therapeutic Advances (VITA): A Study to Explore the Feasibility of using Combined Modalities to Test the Safety of CaridMEMS Device in PAH Patients
IGF::OT::IGF 血管干预/创新和治疗进展 (VITA):一项探索使用组合方式测试 CaridMEMS 设备在 PAH 患者中安全性的可行性的研究
批准号:
8947688
负责人:
RAYMOND Louis Benza
金额:
$28.77万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-12-01 至 2014-11-30

项目摘要

项目成果

RAYMOND Louis Benza的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Vascular Interventions/Innovations and Therapeutic Advances (VITA) Program is a new translational initiative of the National Heart, Lung, and Blood Institute (NHLBI) that enables and accelerates the development of promising diagnostic and therapeutic modalities for unmet and underserved medical needs. The VITA Program provides contract support for early-stage translational development of product candidates in the fields of vascular disorders, thrombotic diseases, and pulmonary hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHORA-Pulmonary Hypertension Outcome Risk Assessment
The Development of a Biatrial Catheter for a Cardiopulmonary Support System in Pulmonary Arterial Hypertension
PHORA: A Clinical Decision Support Tool for Patients with Pulmonary Arterial Hypertension
PHORA: A Clinical Decision Support Tool for Patients with Pulmonary Arterial Hypertension
  • 批准号:
    10187768
  • 项目类别:
  • 资助金额:
    $65.64万
  • 财政年份:
    2017
  • 负责人:
    RAYMOND Louis Benza
  • 依托单位:
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data